Special report: The increasing risk of Lyme disease in Canada

Canadian Veterinary Journal

Volumn 56, Issue 7, 2015, Pages 693-699

  Bouchard, Catherine ^a   Leonard, Erin ^b   Koffi, Jules Konan ^b   Pelcat, Yann ^a   Peregrine, Andrew ^c   Chilton, Neil ^d   Rochon, Kateryn ^e   Lysyk, Tim ^f   Lindsay, L Robbin ^g   Ogden, Nicholas Hume ^a  

^a Laboratory for Foodborne Zoonoses   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f LETHBRIDGE RESEARCH CENTRE   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISPERSAL; CANADA; COMMUNICABLE DISEASES, EMERGING; DOG; DOG DISEASES; IXODES; LYME DISEASE; MICROBIOLOGY; PHYSIOLOGY; VETERINARY;

ANIMAL DISTRIBUTION; ANIMALS; CANADA; COMMUNICABLE DISEASES, EMERGING; DOG DISEASES; DOGS; IXODES; LYME DISEASE;

EID: 84940469255     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Little SE, Heise SR, Blagburn BL, Callister SM, Mead PS. Lyme borreliosis in dogs and humans in the USA. Trends Parasitol 2010;26:213-218.
2. Ogden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H. The emergence of Lyme disease in Canada. Can Med Assoc J 2009;180:1221-1224.
3. Littman MP. Lyme nephritis. J Vet Emerg Crit Car 2013;23:163-173.
4. Leighton PA, Koffi JK, Pelcat Y, Lindsay LR, Ogden NH. Predicting the speed of tick invasion: An empirical model of range expansion for the Lyme disease vector Ixodes scapularis in Canada. J Appl Ecol 2012;49:457-464.
5. Koffi JK, Leighton PA, Pelcat Y, et al. Passive surveillance for I. scapularis ticks: Enhanced analysis for early detection of emerging Lyme disease risk. J Med Entomol 2012;49:400-409.
6. Ogden NH, Bouchard C, Kurtenbach K, et al. Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada. Environ Health Persp 2010;118:909-914.
7. Bouchard C, Beauchamp G, Nguon S, et al. Associations between Ixodes scapularis ticks and small mammal hosts in a newly endemic zone in southeastern Canada: Implications for Borrelia burgdorferi transmission. Ticks Tick-Borne Dis 2011;2:183-190.
8. Tsao JI. Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles. Vet Res 2009;40 (2) 36. doi: 10.1051/vetres/2009019.
9. Schwan TG, Piesman J. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 2002;8:115-121.
10. Cook MJ. Lyme borreliosis: A review of data on transmission time after tick attachment. Int J Gen Med 2015;8:1-8.
11. Ogden NH, Koffi JK, Pelcat Y, Lindsay LR. Environmental risk from Lyme disease in central and eastern Canada: A summary of recent surveillance information. Public Health Agency of Canada. CCDR 2014:40-5.
12. Villeneuve A, Goring J, Marcotte L, Overvelde S. Seroprevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, Ehrlichia canis, and Dirofilaria immitis among dogs in Canada. Can Vet J 2011;52:527-530.
13. Bouchard C, Beauchamp G, Leighton PA, Lindsay R, Belanger D, Ogden NH. Does high biodiversity reduce the risk of Lyme disease invasion? Parasit Vectors 2013; Jul. 1; 6:195. doi: 10.1186/1756-3305-6-195.
14. Scott JD, Lee MK, Fernando K, Jorgensen DR, Durden LA, Morshed MG. Rapid introduction of Lyme disease spirochete, Borrelia burgdorferi sensu stricto, in Ixodes scapularis (Acari: Ixodidae) established at Turkey Point Provincial Park, Ontario, Canada. J Vector Ecol 2008;33:64-69.
15. Ogden NH, Lindsay LR, Hanincova K, et al. Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada. Appl Environ Microb 2008;74:1780-1790.
16. Lindsay LR, Mathison SW, Barker IK, McEwen SA, Gillespie TJ, Surgeoner GA. Microclimate and habitat in relation to Ixodes scapularis (Acari: Ixodidae) populations on Long Point, Ontario, Canada. J Med Entomol 1999;36:255-262.
17. Ogden NH, Radojevic M, Wu XT, Duwuri VR, Leighton PA, Wu JH. Estimated effects of projected climate change on the basic reproductive number of the Lyme disease vector Ixodes scapularis. Environ Health Perspect 2014;122:631-638.
18. Lindsay LR, Mathison SW, Barker IK, McEwen SA, Surgeoner GA. Abundance of Ixodes scapularis (Acari: Ixodidae) larvae and nymphs in relation to host density and habitat on Long Point, Ontario. J Med Entomol 1999;36:243-254.
19. Ogden NH, Barker IK, Beauchamp G, et al. Investigation of ground level and remote-sensed data for habitat classification and prediction of survival of Ixodes scapularis in habitats of southeastern Canada. J Med Entomol 2006;43:403-414.
20. Rogic A, Tessier N, Legendre P, Lapointe FJ, Millien V. Genetic structure of the white-footed mouse in the context of the emergence of Lyme disease in southern Quebec. Ecol Evol 2013;3:2075-2088.
21. Bouchard C, Leighton PA, Beauchamp G, et al. Harvested white-tailed deer as sentinel hosts for early establishing Ixodes scapularis populations and risk from vector-borne zoonoses in Southeastern Canada. J Med Entomol 2013;50:384-393.
22. Werden L, Barker IK, Bowman J, et al. Geography, deer, and host biodiversity shape the pattern of Lyme disease emergence in the thousand islands archipelago of Ontario, Canada. Plos One 2014;9:e85640. doi: 10.1371/journal.pone.0085640
23. Ogden NH, Tsao JI. Biodiversity and Lyme disease: Dilution or amplification? Epidemics-Neth 2009;1:196-206.
24. Lee X, Coyle DR, Johnson DK, et al. Prevalence of Borrelia burgdorferi and Anaplasma phagocytophilum in Ixodes scapularis (Acari: Ixodidae) nymphs collected in managed red pine forests in Wisconsin. J Med Entomol 2014;51:694-701.
25. Laboratory Centre for Disease Control. Consensus conference on Lyme disease, Health Canada, Guelph, Ontario, January 15-16, 1991.
26. Rochon K, Scoles GA, Lysyk TJ. Dispersion and sampling of adult Dermacentor andersoni in rangeland in Western North America. J Med Entomol 2012;49:253-261.
27. Mak S, Morshed M, Henry B. Ecological niche modeling of Lyme disease in British Columbia, Canada. J Med Entomol 2010;47:99-105.
28. Reisen WK. Landscape epidemiology of vector-borne diseases. Annu Rev Entomol 2010;55:461-483.
29. Ogden NH, Lindsay LR, Leighton PA. Predicting the rate of invasion of the agent of Lyme disease Borrelia burgdorferi. J Appl Ecol 2013;50:510-518.
30. Littman MP, Goldstein RE, Labato MA, Lappin MR, Moore GE. ACVIM small animal consensus statement on Lyme disease in dogs: Diagnosis, treatment, and prevention. J Vet Intern Med 2006;20:422-434.
31. Greene C, Straubinger RK, Levy SA. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, Missouri: Elsevier Saunders, 2012.
32. Butler CM, Houwers DJ, Jongejan F, Van Der Kolk JH. Borrelia burgdorferi infections with special reference to horses. A review. Vet Quart 2005;27:147-156.
33. Tuomi J, Rantamäki LK, Tanskanen R. Experimental infection of cattle with several Borrelia burgdorferi sensu lato strains; immunological heterogeneity of strains as revealed in serological tests. Vet Microbiol 1998;60:27-43.
34. Shaw SE, Day MJ, Birtles RJ, Breitschwerdt EB. Tick-borne infectious diseases of dogs. Trends Parasitol 2001;17:74-80.
35. Sykes JE. Lyme borreliosis. In: Sykes JE, ed. Canine and Feline Infectious Diseases. St. Louis, Missouri: Elsevier Saunders, 2014:487-497.
36. Peregrine AS, Barker IK, Abrams-Ogg AC, Woods JP. Screening dogs in Ontario for Borrelia burgdorferi and Ehrlichia canis should be selective rather than routine. Can Vet J 2007;48:673.
37. Levy SA, O'Connor TP, Hanscom JL, Shields P, Lorentzen L, Dimarco AA. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs. Clin Vaccine Immunol 2008;15:115-119.
38. Krupka I, Straubinger RK. Lyme borreliosis in dogs and cats: Background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto. Vet Clin North Am Small Anim Pract 2010;40:1103-1119.
39. Piesman J. Strategies for reducing the risk of Lyme borreliosis in North America. Int J Med Microbiol 2006;296 Suppl 40:17-22.
40. Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. J Am Vet Med Assoc 1993;202:1834-1838.
41. Klingborg DJ, Hustead DR, Curry-Galvin EA, et al. AVMA Council on biologic and therapeutic agents' report on cat and dog vaccines. J Am Vet Med Assoc 2002;221:1401-1407.
42. Mead P, Goel R, Kugeler K. Canine serology as adjunct to human Lyme disease surveillance. Emerg Infect Dis 2011;17:1710-1712.